Julius Clinical is an academic clinical CRO founded in 2008 as a spin-off from the University Medical Center Utrecht (UMCU). We focus on specific therapeutic areas we believe we can add true value to, working closely with recognised academic leaders and networks actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility combined with operational excellence means we are uniquely equipped to assist in providing answers for today’s clinical drug development challenges. We offer end-to-end CRO services to run global clinical trials in CNS including Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, ALS and Hearing Loss. We look forward to meeting you at our booth #1129! Maria Papakrasa Lisa Exalto - Julius Clinical
Julius Clinical is a global Academic CRO with a distinct focus on supporting the development of drugs that provide a significant improvement of medical practice. We offer end-to-end CRO services to run global clinical trials, which are supported by our proprietary scientific site networks and tailor-made operational solutions. We focus on specific therapeutic areas we believe we can add true value to, including Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, ALS and Hearing Loss.